Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $25,061 | 1 | 98.8% |
| Food and Beverage | $191.71 | 5 | 0.8% |
| Education | $105.14 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $25,061 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $126.38 | 1 | $0 (2023) |
| Travere Therapeutics, Inc. | $67.56 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32.53 | 2 | $0 (2021) |
| Vifor Pharma, Inc. | $24.28 | 2 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $17.57 | 1 | $0 (2024) |
| Ardelyx, Inc. | $15.23 | 1 | $0 (2024) |
| Lilly USA, LLC | $13.30 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113.66 | 7 | Travere Therapeutics, Inc. ($67.56) |
| 2023 | $126.38 | 1 | Alexion Pharmaceuticals, Inc. ($126.38) |
| 2022 | $24.28 | 2 | Vifor Pharma, Inc. ($24.28) |
| 2021 | $32.53 | 2 | AstraZeneca Pharmaceuticals LP ($32.53) |
| 2019 | $25,061 | 1 | GENZYME CORPORATION ($25,061) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEPHROLOGY | ||||||
| 01/30/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $13.30 | General |
| 01/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 08/11/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $126.38 | General |
| 06/30/2022 | Vifor Pharma, Inc. | — | Education | In-kind items and services | $12.14 | General |
| 06/30/2022 | Vifor Pharma, Inc. | — | Education | In-kind items and services | $12.14 | General |
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/26/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/30/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Grant | Cash or cash equivalent | $25,061.21 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 702 | 1,707 | $283,595 | $117,105 |
| 2022 | 9 | 675 | 1,484 | $245,665 | $102,187 |
| 2021 | 8 | 570 | 1,334 | $218,410 | $90,947 |
| 2020 | 11 | 709 | 1,469 | $242,705 | $98,731 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 200 | 888 | $124,320 | $54,374 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 208 | 366 | $38,430 | $23,944 | 62.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 140 | 164 | $63,960 | $22,151 | 34.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 55 | 144 | $31,680 | $8,011 | 25.3% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 12 | 47 | $11,750 | $3,076 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 35 | 35 | $6,720 | $3,058 | 45.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 27 | $2,160 | $1,052 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 21 | $1,575 | $1,030 | 65.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 15 | $3,000 | $408.74 | 13.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 187 | 647 | $90,580 | $36,045 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 202 | 403 | $42,410 | $27,138 | 64.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 122 | 132 | $51,480 | $20,449 | 39.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 53 | 138 | $30,360 | $7,878 | 25.9% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 23 | 70 | $17,500 | $4,695 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 40 | 40 | $7,680 | $3,783 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 18 | $1,350 | $876.53 | 64.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 15 | $2,625 | $682.24 | 26.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 21 | $1,680 | $641.02 | 38.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 184 | 630 | $88,200 | $35,487 | 40.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 119 | 293 | $31,145 | $20,641 | 66.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 101 | 107 | $41,730 | $16,654 | 39.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 64 | 156 | $34,320 | $8,992 | 26.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 37 | 37 | $7,340 | $3,590 | 48.9% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 11 | 41 | $10,250 | $2,767 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 30 | 35 | $2,625 | $1,762 | 67.1% |
About Dr. Murad Kheetan, MD
Dr. Murad Kheetan, MD is a Internal Medicine healthcare provider based in Huntington, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1326453952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Murad Kheetan, MD has received a total of $25,358 in payments from pharmaceutical and medical device companies, with $113.66 received in 2024. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Grant" ($25,061).
As a Medicare-enrolled provider, Kheetan has provided services to 2,656 Medicare beneficiaries, totaling 5,994 services with total Medicare billing of $408,970. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Huntington, WV
- Active Since 06/23/2014
- Last Updated 11/18/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326453952
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $25,061
- LOKELMA (Drug) $32.53
- JYNARQUE (Drug) $17.57
- IBSRELA (Drug) $15.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntington
Aamir Cheema, M.d, M.D
Internal Medicine — Payments: $207,509
Kofi Osei, Md, MD
Internal Medicine — Payments: $78,202
Wesam Frandah, Md, MD
Internal Medicine — Payments: $28,363
Rameez Sayyed, Md, MD
Internal Medicine — Payments: $24,444
David Patick, Md, MD
Internal Medicine — Payments: $23,768
Dr. Timothy Saxe, M.d, M.D
Internal Medicine — Payments: $21,802